Lululemon: When Full Price Stops Working
Before the gates: the numbers that make this hard
On paper, Lululemon looks like exactly the kind of business a value investor waits years to find. Five-year average ROE around 34.6%, a debt-free balance sheet, gross margins near 56.6%, and a trailing P/E of 9.5. Any screener worth its salt would surface it at the top of the list.
We passed on it anyway. The qualitative analysis — the four gates below — is where the story stops cooperating with the spreadsheet.
Gate 1: Circle of competence — knowable, with an asterisk
Lululemon designs its own premium yoga and athleisure apparel and sells it almost entirely direct: 811 owned stores as of the end of 2025, plus its own e-commerce. Little wholesale dependence means the retail margin stays in-house. The premium price is justified — or was — by “technical performance plus community,” a mix of product and ambassador-led store classes. The Americas is the largest region; mainland China is the growth axis, with FY26 Q1 revenue up 30% there.
Is it knowable? Yes. Filings, earnings calls (FY2025 results on 2026-03-17, FY26 Q1 on 2026-06-04), and steady coverage of competitors make the business reconstructible from public sources.
Is it predictable? Here we hesitate. A consumer brand is inside our circle as a type, but premium fashion does not have the demand persistence of a cola or a candy bar. The honest question — will the leading premium yoga brand still be the leader in ten years? — has moved toward being a probability bet over the past two years. This is the industry where Dexter Shoe’s lesson applies most directly: fashion moats are chronically overestimated. Gate 1 passes, but with confidence marked low, and the real judgment deferred to Gate 2.
Gate 2: Moat — the failure
The moat’s source is real enough: the brand, plus a partial cost advantage from vertical D2C integration. There are no switching costs and no network effects — the cost of changing your leggings brand is zero.
The pricing power evidence used to be excellent. Historically roughly 95% of product sold at full price, with industry-leading gross margins around 57–58%. But the litmus test has recently inverted. Through 2025–26, persistent markdowns across product lines became a recurring theme in coverage. FY26 Q1 gross margin fell sharply year over year to the mid-54% range (company figures, tariffs included), and operating income dropped 37%. A company that can raise prices without a prayer meeting is becoming one that cannot move inventory without a discount.
The direction is narrowing, on four counts:
- Share erosion. The US athleisure share of ~21% still leads, but Alo Yoga has grown rapidly in the premium D2C segment (to roughly 14%, with cultural dominance among Gen Z) and Vuori (valued at $5.5 billion, preparing an IPO) attacks precisely Lululemon’s weak spots: style, menswear, younger customers.
- Core market shrinking. Americas comparable sales fell 5% in FY26 Q1 in dollar terms, and the company itself guided to a high-single-digit annual decline in the region.
- Product misses. Management admitted on the call that new product launches “failed to resonate.” Fashion risk is currently beating the moat narrative.
- China’s +30% is market penetration, not moat. Real growth, but it is evidence of a new market, not of durable advantage — and reports suggest even that growth rate is decelerating.
A note for the AI era: neutral to negative. AI does not reinforce a brand moat here; it lowers the cost of influencer- and social-media-driven brand building, which makes Alo-style entrants more marketing-efficient. The barrier itself is thinning.
Verdict: fail. A brand moat can be identified, but its direction is clearly narrowing and the pricing-power litmus test has failed.
Gate 3: Management — noted, but moot
Capital allocation has been reasonably good. Debt-free operations; the only blemish is the ~$500 million Mirror acquisition and write-off, painful in principle but not fatal, and the loss was acknowledged and cleaned up. Buybacks grew from ~$0.56 billion in 2024 to ~$1.6 billion in 2025, with a further $1.0 billion authorized in December 2025 — buying during a falling stock price is the right direction, though buying during falling earnings still needs post-hoc verification.
The retained-earnings test, however, is turning into a failure: despite large retained profits over five years, the market cap is down 46% from its peak in 2026, breaking the dollar-for-dollar rolling test.
On candor and alignment: CEO Calvin McDonald resigned effective 2026-01-31 with no successor named (interim CEO Meghan Frank), and a proxy dispute is underway — a leadership vacuum that alone would warrant suspension of judgment. Credit where due: the interim CEO admitted the product missteps on the call.
Gate 4: Price — cheap, and not cheap enough
Trailing owner earnings are $1.39 billion, a 10.5% yield. But that is a rearview number. FY2025 net income was ~$1.6 billion (-13% YoY), free cash flow fell 42% to $0.92 billion, and FY26 guidance implies flat-to-declining revenue. A conservative normalized owner earnings estimate is $1.0–1.2 billion.
At a cautious 10x on those normalized figures — and even no-growth 10x may be generous in a declining-earnings phase — intrinsic value sits at roughly $10–12 billion. The current market cap of $13.3 billion is above the top of that range.
The P/E of 9.5 is an illusion built on trailing earnings. The 10.5% owner-earnings yield comfortably beats the 10-year Treasury at 4.3% today, but if earnings keep shrinking at double-digit rates, that advantage evaporates within two to three years. On normalized figures, there is no margin of safety. The price is not cheap; the earnings are falling — the textbook value trap setup.
Verdict
Rejected at Gate 2. The quantitative profile — 34.6% average ROE, no debt, 56.6% gross margin, P/E 9.5 — is exactly what a screen should find. The qualitative picture is what the screen cannot see: a full-price model breaking down, Americas comps at -5%, Alo and Vuori taking aim at precisely the company’s weak spots, product missteps admitted by management, and a CEO seat left empty amid a proxy fight. The failed pricing-power litmus test was decisive. A low P/E that front-runs declining earnings is not a margin of safety. (One data note: the zero debt figure is genuine — no borrowings — though operating lease liabilities of roughly $1.6–1.8 billion imply a lease-adjusted D/E near 0.35, still within bounds.)
What would change it: two consecutive quarters of positive Americas comparable sales, or a recovery of gross margin toward 57% alongside full-price selling and a permanent CEO with a credible product strategy — and this thesis gets re-reviewed as a solvable, one-to-two-year stumble rather than a structural break.
This analysis is AI-generated, educational, and not investment advice. Figures may contain errors or be delayed. Disclaimer